Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities ; volume:9 ; number:1 ; day:4 ; month:4 ; year:2017 ; pages:1-15 ; date:12.2017
Clinical epigenetics ; 9, Heft 1 (4.4.2017), 1-15, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Micevic, Goran
- Beteiligte Personen und Organisationen
-
Theodosakis, Nicholas
Bosenberg, Marcus
SpringerLink (Online service)
- DOI
-
10.1186/s13148-017-0332-8
- URN
-
urn:nbn:de:1111-201704226845
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Micevic, Goran
- Theodosakis, Nicholas
- Bosenberg, Marcus
- SpringerLink (Online service)
Ähnliche Objekte (12)
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma
Aberrant DNA methylation patterns in diabetic nephropathy
Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
Aberrant DNA methylation of Tgfb1 in diabetic kidney mesangial cells
Aberrant DNA Methylation in Bladder Cancer among Saudi Arabia Population
Pan-cancer predictions of transcription factors mediating aberrant DNA methylation
Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
Aberrant DNA methylation in t(8;21) acute myeloid leukemia
Tackling malignant melanoma epigenetically: histone lysine methylation
Opportunities for pharmacoproteomics in biomarker discovery
Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma
Aberrant DNA methylation patterns in diabetic nephropathy
Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
Aberrant DNA methylation of Tgfb1 in diabetic kidney mesangial cells
Aberrant DNA Methylation in Bladder Cancer among Saudi Arabia Population
Pan-cancer predictions of transcription factors mediating aberrant DNA methylation
Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
Aberrant DNA methylation in t(8;21) acute myeloid leukemia
Tackling malignant melanoma epigenetically: histone lysine methylation
Opportunities for pharmacoproteomics in biomarker discovery
Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma
Aberrant DNA methylation patterns in diabetic nephropathy
Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
Aberrant DNA methylation of Tgfb1 in diabetic kidney mesangial cells
Aberrant DNA Methylation in Bladder Cancer among Saudi Arabia Population
Pan-cancer predictions of transcription factors mediating aberrant DNA methylation
Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
Aberrant DNA methylation in t(8;21) acute myeloid leukemia
Tackling malignant melanoma epigenetically: histone lysine methylation
Opportunities for pharmacoproteomics in biomarker discovery